Skip to main content
. 2021 May 7;48(4):2943–2952. doi: 10.1007/s00068-021-01674-4

Table 4.

Postoperative outcomes

FNB (N = 118) CFNC (N = 178) No loco-regional anaesthesia (N = 112) p value
Per hour opioid use
Preoperatively in ml M (SD) 0.49 (2.2) 0.23 (0.38) 0.18 (0.30) 0.106
Intraoperatively in ml M (SD) 17.5 (9.6) 15.5(10.7) 19.7 (12.5) 0.007
Postoperatively at the recovery room M (SD) 0.36 (1.1) 0.37 (0.74) 0.93 (1.5)  < 0.001
Postoperatively 2 days after surgery M (SD) 0.05 (0.11) 0.06 (0.15) 0.1 (0.17) 0.015
Total opioid use
Preoperatively in ml M (SD) 7.7 (45.9) 6.4 (10.5) 2.8 (4.0) 0.328
Intraoperatively in ml M (SD) 31.1 (13.6) 28.6 (15.9) 34.5 (16.2) 0.007
Postoperatively at the recovery room M (SD) 1.2 (3.4) 1.9 (3.4) 3.3 (4.5)  < 0.001
Postoperatively 2 days after surgery M (SD) 2.1 (5.1) 3.1 (7.1) 3.3 (6.9) 0.015
Complications
Falls n (%) 2 (1.7) 4 (2.3) 0 (0) 0.675
Delirium n (%) 15 (12.7) 20 (11.4) 8 (7.1) 0.354
Anaemia n (%) 30 (25.4) 64(36.4) 39(34.8) 0.126
Urinary tract infection n (%) 9 (7.6) 9(5.1) 2(1.8) 0.122
CVA n (%) 0(0.0) 0(0.0) 1(0.9) 0.268
Myocardial Infarction n (%) 0(0.0) 1(0.6) 2(1.8) 0.270
Decubital ulcer n (%) 0(0.0) 0(0.0) 1(0.9) 0.268
Wound infection n (%) 2(1.1) 1(0.8) 0(0.0) 0.540
Patients with a complicated course n (%) 50(42.2) 88(50) 49(43.8) 0.430
Mortality
30-day mortality 10(8.5) 14(8.0) 14(12.5) 0.409
90-day mortality 14(11.9) 32(18.4) 17(15.2) 0.317
1-year mortality 21(17.8) 58(33.3) 32(28.8) 0.013
Total HLOS in days M (SD) 9.4 (5.0) 9.3 (4.7) 8.8 (3.9) 0.590

n number of patients, M Mean, SD Standard Deviation, HLOS hospital length of stay, FNB femoral nerve block, CFNC continuous femoral nerve catheter, CVA cerebral vascular accident